Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

NCT00134875 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

9

Enrollment

NIH

Sponsor class

Conditions

Opioid-Related Disorders

Interventions

DRUG: Buprenorphine/naloxone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)